BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 16259912)

  • 1. [Model for predicting survival of patients with severe virus hepatitis and its clinical application].
    Shan J; Xu RP; Ding XJ; Wang HF; Lin W; Ma B; Dong PL; Zhang B; Ding HG
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Oct; 17(10):586-8. PubMed ID: 16259912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of short-term prognosis on patients with chronic severe hepatitis B using the model for end-stage liver disease].
    Zhou J; He WF; Tang XE
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):416-8. PubMed ID: 17631710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Model for end-stage liver disease-sodium predicts prognosis in patients with chronic severe hepatitis B.
    Cai CJ; Chen HA; Lu MQ; Chen GH
    Chin Med J (Engl); 2008 Oct; 121(20):2065-9. PubMed ID: 19080277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical value of Child-Turcotte-Pugh and model for end-stage liver disease score to predict the prognosis of chronic severe hepatitis].
    Jiang ZS; Jiang JN
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):412-5. PubMed ID: 17631709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of pretransplant MELD score on posttransplant outcome in orthotopic liver transplantation for patients with acute-on-chronic hepatitis B liver failure.
    Wang ZX; Yan LN; Wang WT; Xu MQ; Yang JY
    Transplant Proc; 2007 Jun; 39(5):1501-4. PubMed ID: 17580172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis.
    Giannini E; Botta F; Testa E; Romagnoli P; Polegato S; Malfatti F; Fumagalli A; Chiarbonello B; Risso D; Testa R
    Am J Gastroenterol; 2002 Nov; 97(11):2855-60. PubMed ID: 12425560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of prognosis on patients with severe viral hepatitis using the model for end-stage liver disease].
    Wong ZH; Cai SQ
    Zhonghua Gan Zang Bing Za Zhi; 2005 Apr; 13(4):249-51. PubMed ID: 15850508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of the prognosis of patients with acute-on-chronic hepatitis B liver failure using the model for end-stage liver disease scoring system and a novel logistic regression model.
    Sun QF; Ding JG; Xu DZ; Chen YP; Hong L; Ye ZY; Zheng MH; Fu RQ; Wu JG; Du QW; Chen W; Wang XF; Sheng JF
    J Viral Hepat; 2009 Jul; 16(7):464-70. PubMed ID: 19413694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A retrospective analysis of therapeutic outcome of various types of severe virus hepatitis].
    Sui Y; Xu J; Gao L; He C; Han Z
    Zhonghua Gan Zang Bing Za Zhi; 2001 Jul; 9 Suppl():55-7. PubMed ID: 11509141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of prognostic factors of and to establish a predictive model for patients with chronic severe hepatitis].
    Zhang N; Wang YM; Deng GH; Yi D
    Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):730-3. PubMed ID: 16248942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting clinical and economic outcomes after liver transplantation using the Mayo primary sclerosing cholangitis model and Child-Pugh score. National Institutes of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database Group.
    Talwalkar JA; Seaberg E; Kim WR; Wiesner RH
    Liver Transpl; 2000 Nov; 6(6):753-8. PubMed ID: 11084063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application of Model for end-stage liver disease to predict the prognosis of and curative effect for chronic severe hepatitis].
    Liu Q; Liu Z; Wang TL; Zhang LL
    Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(25):1773-7. PubMed ID: 16253168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early mortality in Taiwanese lamivudine-treated patients with chronic hepatitis B-related decompensation: evaluation of the model for end-stage liver disease and index scoring systems as prognostic predictors.
    Dai CY; Chuang WL; Hou NJ; Lee LP; Hsieh MY; Lin ZY; Chen SC; Huang JF; Hsieh MY; Wang LY; Tsai JF; Wen-Yu ; Yu ML
    Clin Ther; 2006 Dec; 28(12):2081-92. PubMed ID: 17296464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fulminant hepatitis in a tropical population: clinical course, cause, and early predictors of outcome.
    Acharya SK; Dasarathy S; Kumer TL; Sushma S; Prasanna KS; Tandon A; Sreenivas V; Nijhawan S; Panda SK; Nanda SK; Irshad M; Joshi YK; Duttagupta S; Tandon RK; Tandon BN
    Hepatology; 1996 Jun; 23(6):1448-55. PubMed ID: 8675163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term entecavir therapy of chronic severe hepatitis B.
    Chen J; Han JH; Liu C; Yu RH; Li FZ; Li QF; Gong GZ
    Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):261-6. PubMed ID: 19502165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Outcome of the kidney transplant recipients with chronic hepatitis B virus].
    Chen ZY; Lai YT; Huang WJ; Cai YQ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 31(3):392-5. PubMed ID: 16859131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of compensated viral B and D cirrhosis.
    Gheorghe L; Iacob S; Simionov I; Vadan R; Gheorghe C; Iacob R; Parvulescu I; Constantinescu I
    Rom J Gastroenterol; 2005 Dec; 14(4):329-35. PubMed ID: 16400347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early response to lamivudine therapy in clinically non-cirrhotic chronic hepatitis B patients with decompensation.
    Dai CY; Yu ML; Hsieh MY; Lee LP; Hou NJ; Huang JF; Chen SC; Lin ZY; Hsieh MY; Wang LY; Tsai JF; Chang WY; Chuang WL
    Liver Int; 2007 Dec; 27(10):1364-70. PubMed ID: 17900250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applicability of MELD as a short-term prognostic indicator in patients with chronic liver disease: an Indian experience.
    Mishra P; Desai N; Alexander J; Singh DP; Sawant P
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1232-5. PubMed ID: 17688663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.